Case Study: a Fortune 100 life sciences company reduces study material costs with Acolad

Fortune 100 Life Sciences Company cuts study material costs by 50% with Acolad

The customer, a Fortune 100 life sciences company, faced a challenge supporting its exponential growth in global clinical trials. Its existing process for creating and translating patient engagement materials was inefficient and time-consuming for its operations team. The vendor, Acolad, was engaged to help streamline the translation of these critical study documents.

Acolad implemented a solution using its Global Translation Center portal and took over key coordination tasks. This streamlined the workflow, directly involved local trial managers, and integrated with the client's eTMF system. As a result, Acolad helped the customer achieve a 50% reduction in costs and shaved three weeks from the standard turnaround time, representing a 20-30% time savings.